Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects

NCT01327872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic
Acute Idiopathic Thrombocytopenic Purpura
Chronic Thrombocytopenia

Interventions

DRUG: E5501 40 mg 2 x 20-mg tablets, orally, fasted
DRUG: E5501 40 mg 2 x 20-mg tablets, orally, with food
DRUG: E5501 40mg 2 x 20-mg tablets, orally, fasted
DRUG: E5501 40 mg 2 x 20-mg tablets, orally, with food

Sponsor

Eisai Inc.